These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 34240399)

  • 1. Mortality reduction with levosimendan in patients with heart failure: Current evidence is underpowered.
    Sanfilippo F; La Via L; Merola F; Astuto M
    Cardiol J; 2021; 28(5):798-799. PubMed ID: 34240399
    [No Abstract]   [Full Text] [Related]  

  • 2. Levosimendan in patients with decompensated heart failure.
    Rosa EM; Osório AP; Scopel L
    Arq Bras Cardiol; 2008 Aug; 91(2):119. PubMed ID: 18709265
    [No Abstract]   [Full Text] [Related]  

  • 3. Can we believe in levosimendan?
    Follath F
    Arq Bras Cardiol; 2008 Mar; 90(3):146-7. PubMed ID: 18392391
    [No Abstract]   [Full Text] [Related]  

  • 4. eComment. Consider trying levosimendan.
    Desimonas NA
    Interact Cardiovasc Thorac Surg; 2013 Oct; 17(4):715. PubMed ID: 24065759
    [No Abstract]   [Full Text] [Related]  

  • 5. eComment. Levosimendan in adult patients undergoing cardiac surgery.
    Hajj-Chahine J
    Interact Cardiovasc Thorac Surg; 2013 Oct; 17(4):715. PubMed ID: 24065758
    [No Abstract]   [Full Text] [Related]  

  • 6. eComment. Preoperative levosimendan administration in cardiac surgery patients.
    Yavuz S; Eris C; Ata Y; Turk T
    Interact Cardiovasc Thorac Surg; 2013 Oct; 17(4):714-5. PubMed ID: 24065757
    [No Abstract]   [Full Text] [Related]  

  • 7. Levosimendan: a calcium-sensitizing agent for the treatment of patients with decompensated heart failure.
    Lehtonen L
    Curr Heart Fail Rep; 2004 Sep; 1(3):136-44. PubMed ID: 16036037
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Levosimendan preoperative.
    Rognoni A; Lupi A; Cavallino C; Veia A; Bacchini S; Rosso R; Secco GG; Bongo AS
    Curr Pharm Des; 2013; 19(22):3974-8. PubMed ID: 23228313
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Levosimendan use in several scenarios of acute heart failure.
    Tavares M; Andrade AC; Mebazaa A
    Arq Bras Cardiol; 2008 Mar; 90(3):211-5. PubMed ID: 18392402
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety and efficacy of levosimendan in patients with cardiac amyloidosis.
    Aimo A; Rapezzi C; Arzilli C; Vergaro G; Emdin M
    Eur J Intern Med; 2020 Oct; 80():114-116. PubMed ID: 32631802
    [No Abstract]   [Full Text] [Related]  

  • 11. Levosimendan for the treatment of acute heart failure syndromes.
    Parissis JT; Filippatos G; Farmakis D; Adamopoulos S; Paraskevaidis I; Kremastinos D
    Expert Opin Pharmacother; 2005 Dec; 6(15):2741-51. PubMed ID: 16316312
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The use of levosimendan in comparison and in combination with dobutamine in the treatment of decompensated heart failure.
    Cavusoglu Y
    Expert Opin Pharmacother; 2007 Apr; 8(5):665-77. PubMed ID: 17376021
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety and efficacy of a novel calcium sensitizer, levosimendan, in patients with left ventricular failure due to an acute myocardial infarction. A randomized, placebo-controlled, double-blind study (RUSSLAN).
    Moiseyev VS; Põder P; Andrejevs N; Ruda MY; Golikov AP; Lazebnik LB; Kobalava ZD; Lehtonen LA; Laine T; Nieminen MS; Lie KI;
    Eur Heart J; 2002 Sep; 23(18):1422-32. PubMed ID: 12208222
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Levosimendan improves cardiac function and survival in rats with angiotensin II-induced hypertensive heart failure.
    Biala A; Martonen E; Kaheinen P; Levijoki J; Finckenberg P; Merasto S; Louhelainen M; Muller DN; Luft FC; Mervaala E
    Hypertens Res; 2010 Oct; 33(10):1004-11. PubMed ID: 20811386
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Levosimendan treatment of severe acute congestive heart failure refractory to dobutamine/milrinone in children].
    Prijić S; Rakić S; Nikolić L; Jovicić B; Stajević M; Vukomanović V; Kosutić J
    Vojnosanit Pregl; 2011 Nov; 68(11):979-84. PubMed ID: 22191317
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tricuspid valve replacement and levosimendan.
    Cicekcioglu F; Parlar AI; Altinay L; Yay K; Katircioglu SF
    Gen Thorac Cardiovasc Surg; 2008 Nov; 56(11):559-62. PubMed ID: 19002757
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heart failure. Tardy but intact--publication of REVIVE trial results welcomed.
    Cully M
    Nat Rev Cardiol; 2013 Jun; 10(6):297. PubMed ID: 23609172
    [No Abstract]   [Full Text] [Related]  

  • 18. Efficacy and safety of levosimendan and dobutamine in heart failure: A systematic review and meta-analysis.
    Jaguszewski MJ; Gasecka A; Targonski R; Filipiak KJ; Szarpak L
    Cardiol J; 2021; 28(3):492-493. PubMed ID: 33843036
    [No Abstract]   [Full Text] [Related]  

  • 19. Intravenous levosimendan treatment is cost-effective compared with dobutamine in severe low-output heart failure: an analysis based on the international LIDO trial.
    Cleland JG; Takala A; Apajasalo M; Zethraeus N; Kobelt G
    Eur J Heart Fail; 2003 Jan; 5(1):101-8. PubMed ID: 12559222
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Levosimendan in acute decompensated heart failure: systematic review and meta-analysis.
    Ribeiro RA; Rohde LE; Polanczyk CA
    Arq Bras Cardiol; 2010 Aug; 95(2):230-7. PubMed ID: 20549133
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.